MedPath

Effect of Bupropion in diabetes patients with mild depressio

Phase 4
Conditions
Health Condition 1: E119- Type 2 diabetes mellitus without complications
Registration Number
CTRI/2022/10/046411
Lead Sponsor
ALL INDIA INSTITUTE OF MEDICAL SCIENCES JODHPUR
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Closed to Recruitment of Participants
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Age of 30 – 70 years

2.Diagnosis of type 2 Diabetes Mellitus as per IDF criteria

3.Duration of T2 DM for 5 years or more

4.HbA1c between 6.5% and 12%

5.Having a score of 5-9 (mild) on Patient Health Questionnaire-9

Exclusion Criteria

1.Type 1 Diabetes Mellitus

2.Patient who had any significant neurological disorders, or with any significant medical or surgical condition

3.History of traumatic brain injury

4.Patient having any co-morbid psychiatric disorder other than mild depression, or history of any psychiatric illness

5.Treatment with antipsychotic or antidepressant medications, benzodiazepines, dopaminergic medications, monoamine oxidase inhibitors, or amantadine within the last 4 weeks before study participation

6.Pregnant and lactating women

7.History of allergy/intolerance to Bupropion

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath